Evidence map›Paper›PMID 40453081›Full record

ArticleFrontiers in immunology2025

Expression of salivary hepcidin and its inducer, interleukin 6 as well as type I interferons are significantly elevated in infants with poor oral rotavirus vaccine take in South Africa.

Vusumuzi Mabasa, Mapeseka L Seheri, Cliff A Magwira

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Vusumuzi MabasaDiarrheal Research Pathogens Unit (DPRU), Department of Virology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Mapeseka L SeheriDiarrheal Research Pathogens Unit (DPRU), Department of Virology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Cliff A MagwiraDiarrheal Research Pathogens Unit (DPRU), Department of Virology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The metabolism of nutritional iron, required by viruses to replicate and proliferate, is regulated by hepcidin, a peptide hormone of 25 amino acids. Overexpression of hepcidin results in iron deficiency anemia (IDA), while its downregulation can lead to an iron overload. Recently, IDA has been highlighted for its role in the impairment of adaptive immunity and poor vaccine effectiveness. Here, we assessed the possible role of IDA in oral rotavirus (RV) vaccine take among South African infants. Methodology: Paired stool and unstimulated saliva were collected from oral RV vaccinated infants, who attended a routine immunization program at Oukasie Healthcare clinic, north of Pretoria, South Africa, to decide vaccine shedders (n = 20) and non-shedders (n = 18). IDA was determined by assaying the salivary hepcidin levels using an ELISA kit, while expression of hepcidin, hepcidin inducer IL-6, Interferon I (IFN I) and IFN-γ were determined by qPCR. Results: There were no significant differences in the average hepcidin levels between vaccine shedders and non-shedders ( Summary: Collectively, our observations suggest a possible role for IDA in impediment of oral RV vaccine take among South African infants.

Indexed as

HepcidinsInterferon Type IInterleukin-6RotavirusRotavirus InfectionsRotavirus VaccinesSalivaAdministration, OralAnemia, Iron-DeficiencyFemaleHumansInfantMaleSouth AfricaHepcidinsIL6 protein, humanInterferon Type IInterleukin-6Rotavirus VaccineshepcidinIL-6interferonsiron deficiency anemiarotavirus vaccineshedding

Identifiers

PMID40453081
PMCPMC12122446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.